GDTC
CytoMed TherapeuticsยทNASDAQ
--
--(--)
--
--(--)
7.58 / 10
Outperform
Liquidity flow evaluation: 7.58/10 demonstrating robust fund flow characteristics. Optimistic block and Large patterns are mitigated by pessimistic overall, Small, Medium, and Extra-large indicators, pointing to positive flow perspective.
Fund Flow Rating
What is the market sentiment for GDTC?
- GDTC holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.58/10 (Outperform).
